Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 159

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease

Perry, Nicolette S L, Houghton, Peter J, Sampson, Julia, Theobald, Anthony E, Hart, Stephen, Lis-Balchin, Maria, Hoult, J Robin S, Evans, Patricia, Jenner, Peter, Milligan, Stuart, Perry, Elaine K·2001·Journal of Pharmacy and Pharmacology

Abstract

Salvia lavandulaefolia Vahl. (Spanish sage) essential oil and individual monoterpenoid constituents have been shown to inhibit the enzyme acetylcholinesterase in-vitro and in-vivo. This activity is relevant to the treatment of Alzheimer's disease, since anticholinesterase drugs are currently the only drugs available to treat Alzheimer's disease. Other activities relevant to Alzheimer's disease include antioxidant, anti-inflammatory and estrogenic effects. Results of in-vitro tests for these activities are reported here for S. lavandulaefolia extracts, the essential oil and its major constituents. Antioxidant activity (inhibition of bovine brain liposome peroxidation) was found in the EtOH extract of the dried herb (5 mg mL−1) and the monoterpenoids (0.1 M) α- and β-pinene and 1,8-cineole. Thujone and geraniol had lower antioxidant effects, while camphor had no antioxidant effects. Possible anti-inflammatory activity (eicosanoid inhibition in rat leucocytes) was found in the EtOH extract (50 μg mL−1) and was shown by the monoterpenoids α-pinene and geraniol (0.2 mM), but not 1,8-cineole, thujone or camphor. Possible estrogenic activity (via induction of β-galactosidase activity in yeast cells) was found in the essential oil (0.01 mg mL−1) and the monoterpenoid geraniol (0.1–2 mM). 1,8-Cineole, α- and β-pinene and thujone did not exhibit estrogenic activity in this analysis. These results demonstrate that S. lavandulaefolia, its essential oil and some chemical constituents have properties relevant to the treatment of Alzheimer's disease and provide further data supporting the value of carrying out clinical studies in patients with Alzheimer's disease using this plant species.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1211/0022357011777846

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 45

  1. Abelson, 1994, Methods in Enzymology, Vol 234, 443, 10.1016/0076-6879(94)34115-X · DOI
  2. Adam, 1998, Antifungal activities of Origanum vulgare subsp. hirtum, Mentha spicata, Lavandula augustifolia, and Salvia fruticosa essential oils against human pathogenic fungi, J. Agric. Food Chem., 46, 1739, 10.1021/jf9708296 · DOI · Paper page
  3. Aisen, 1996, Inflammation and Alzheimer's disease, Mol. Chem. Neuropathol., 28, 83, 10.1007/BF02815208 · DOI
  4. Aruoma, 1996, Assessment of potential prooxidant and anti-oxidant actions, JAOCS, 73, 1617, 10.1007/BF02517962 · DOI
  5. Aruoma, 1996, An evaluation of the antioxidant and antiviral action of the extracts of rosemary and provencal herbs, Food Chem. Toxicol., 34, 449, 10.1016/0278-6915(96)00004-X · DOI · Paper page
  6. Bartram, 1995, Encyclopaedia of Herbal Medicine, 379
  7. Behl, 1997, Neuroprotection against oxidative stress by estrogens: structure-activity relationship, Am. Soc. Pharmacol. Exp. Ther., 51, 535
  8. Bingol, 1995, A review of terrestrial plants and marine organisms having antiinflammatory activity, Int. J. Pharmacog., 33, 81, 10.3109/13880209509055206 · doi:10.3109/13880209509055206
  9. BirkHäuser, 2000, Oestrogens and Alzheimer's disease, Int. J. Geriatr. Psychiatry, 15, 600, 10.1002/1099-1166(200007)15:7<600::AID-GPS155>3.0.CO;2-7 · DOI
  10. Bouchet, 1998, Radical scavenging activity and antioxidant properties of tannins from Guiera senegalensis (Combretaceae), Phytother. Res., 12, 159, 10.1002/(SICI)1099-1573(199805)12:3<159::AID-PTR209>3.0.CO;2-C · DOI
  11. Brautigam, 1998, Treatment of age-related memory complaints with Ginkgo biloba extract: a randomised double blind placebo-controlled study, Phytomedicine, 5, 425, 10.1016/S0944-7113(98)80038-X · DOI
  12. Breitner, 1996, Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal, Neurobiol. Aging, 17, 789, 10.1016/0197-4580(96)00109-1 · DOI · Paper page
  13. Carr, 1997, Current concepts in the pathogenesis of Alzheimer's disease, Am. J. Med., 103, 3S, 10.1016/S0002-9343(97)00262-3 · DOI
  14. Cooper, 2000, Key issues in Alzheimer's disease inflammation, Neurobiol. Aging, 21, 451, 10.1016/S0197-4580(00)00148-2 · DOI
  15. Culvelier, 1996, Antioxidant activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary, JAOCS, 73, 645, 10.1007/BF02518121 · DOI · Paper page
  16. De Vries, 1997, The blood-brain barrier in neuroinflammatory diseases, Pharmacol. Rev., 49, 143
  17. Dorman, 1995, Evaluation in vitro of plant essential oils as natural antioxidants, J. Essent. Oil. Res., 7, 645, 10.1080/10412905.1995.9700520 · DOI · Paper page
  18. Frölich, 1995, Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidant treatment, Drug Res., 45, 443
  19. Gambassi, 1996, Oestrogen and Alzheimer's disease, Lancet, 348, 1027, 10.1016/S0140-6736(05)64952-5 · doi:10.1016/s0140-6736(05)64952-5
  20. Graven, 1992, Antimicrobial and antioxidative properties of the volatile (essential oil) of Artemisia afra Jacq, Flav. Frag. J., 7, 121, 10.1002/ffj.2730070305 · doi:10.1002/ffj.2730070305
  21. Green, 1998, Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione, Neuroscience, 84, 7, 10.1016/S0306-4522(97)00595-2 · DOI · Paper page
  22. Halliwell, 1995, Antioxidant characterization: methodology and mechanism, Biochem. Pharmacol., 49, 1341, 10.1016/0006-2952(95)00088-H · DOI · Paper page
  23. Harborne, 1991, Ecological Chemistry and Biochemistry of Plants Terpenoids
  24. Hernandez-Perez, 1995, Analgesic, antiinflammatory, antipyretic and hematological effects of aethiopinene, an omicron-naphthoquinone diterpenoid from Salvia aethiopis roots and two hemisynthetic derivatives, Planta Med., 61, 505, 10.1055/s-2006-959358 · doi:10.1055/s-2006-959358
  25. Huang, 1996, Antioxidant activity of carnosic acid and methyl carnosate in bulk oils and oil-in-water emulsions, J. Agric. Food Chem., 44, 2951, 10.1021/jf960068r · DOI
  26. Jiménez, 1995, Effects of Salvia lavandulifolia Vahl. ssp. Oxyodon extract on pancreatic endocrine tissue in steptozotocin-diabetic rates, Phytother. Res., 9, 536, 10.1002/ptr.2650090717 · doi:10.1002/ptr.2650090717
  27. Jordan, 1998, Designer estrogens, Sci. Am., 279, 60, 10.1038/scientificamerican1098-60 · doi:10.1038/scientificamerican1098-60
  28. Kang, 1997, Antioxidant effects of Salvia miltiorrhiza, Arch. Pharmacol. Res., 20, 496, 10.1007/BF02973947 · DOI
  29. Kanowski, 1997, Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia, Phytomedicine, 4, 3, 10.1016/S0944-7113(97)80021-9 · DOI
  30. Le Bars, 1997, A placebo-controlled, double blind, randomized trial of an extract of Ginkgo biloba for dementia, JAMA, 278, 1327, 10.1001/jama.1997.03550160047037 · DOI · Paper page
  31. Littlefield, 1990, A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in ishikawa cells: estrogenic action of delta 5 adrenal steroids, Endocrinology, 127, 2757, 10.1210/endo-127-6-2757 · DOI · Paper page
  32. Masaki, 1995, Active-oxygen scavenging activity of plant extracts, Biol. Pharm. Bull., 18, 162, 10.1248/bpb.18.162 · DOI · Paper page
  33. Moroney, 1988, Selectivity of neutrophil 5-lipoxygenase and cyclooxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids, J. Pharm. Pharmacol., 40, 787, 10.1111/j.2042-7158.1988.tb05173.x · DOI · Paper page
  34. Mulnard, 2000, Estrogen replacement therapy for treatment of mild to moderate Alzheimers disease — A randomised controlled trial, J. Am. Med. Ass., 283, 1007, 10.1001/jama.283.8.1007 · DOI · Paper page
  35. Murray, 1998, Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus, J. Biol. Chem., 273, 12 161, 10.1074/jbc.273.20.12161 · DOI
  36. Pratico, 2000, Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease, Am. J. Med., 109, 577, 10.1016/S0002-9343(00)00547-7 · DOI · Paper page
  37. Rogers, 1995, Inflammation as a pathogenic mechanism in Alzheimer's disease, Drug Res., 45, 439
  38. Routledge, 1996, Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen, Environ. Toxicol. Chem., 15, 241, 10.1002/etc.5620150303 · DOI · Paper page
  39. Santos, 1997, Mast cell involvement in the rat paw oedema response to 1,8-cineole, the main constituent of eucalyptus and rosemary oils, Eur. J. Pharmacol., 331, 253, 10.1016/S0014-2999(97)01013-3 · DOI
  40. Simpkins, 1997, Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease, Am. J. Med., 103, 19S, 10.1016/S0002-9343(97)00260-X · DOI · Paper page
  41. Small, 1997, Diagnosis and treatment of Alzheimer disease and related disorders, JAMA, 278, 1363, 10.1001/jama.1997.03550160083043 · DOI · Paper page
  42. Sugaya, 2000, New anti-inflammatory treatment strategy in Alzheimer's disease, Jpn. J. Pharmacol., 82, 85, 10.1254/jjp.82.85 · DOI
  43. Tariot, 2000, A 5-month, randomised placebo-controlled trial of galantamine in AD, Am. Acad. Neurol., 54, 2269
  44. Wagner, 1986, In vitro inhibition of prostaglandin biosynthesis by essential oils and phenolic compounds, Planta Med, 184, 10.1055/s-2007-969117 · DOI
  45. Xiao, 1998, Effects of estrogen agonists on amphetamine-stimulated dopamine release, Synapse, 2, 379, 10.1002/(SICI)1098-2396(199808)29:4<379::AID-SYN10>3.0.CO;2-M · doi:10.1002/(sici)1098-2396(199808)29:4<379::aid-syn10>3.0.co;2-m

Cited by

See all 159

Metadata

Authors
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis-Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P., Milligan, S., & Perry, E. K.
Venue
Journal of Pharmacy and Pharmacology
Published
2001-10-01
Volume
53
Issue
10
Pages
1347-1356
ISSN
  • 0022-3573 (ISSN-L)
  • 2042-7158
OpenAlex
W1990307779
Cited by
159
References
2
FWCI
9.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. https://app.cochat.ai/papers/10.1211/0022357011777846
The paper
Perry, N. S. L., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis-Balchin, M., Hoult, J. R. S., Evans, P., Jenner, P., Milligan, S., & Perry, E. K. (2001). In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/0022357011777846

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.